Bourne Lent Asset Management Inc Bristol Myers Squibb CO Transaction History
Bourne Lent Asset Management Inc
- $261 Million
- Q2 2024
A detailed history of Bourne Lent Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 158,687 shares of BMY stock, worth $8.08 Million. This represents 2.53% of its overall portfolio holdings.
Number of Shares
158,687
Previous 162,552
2.38%
Holding current value
$8.08 Million
Previous $8.82 Million
25.24%
% of portfolio
2.53%
Previous 3.56%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.08 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.66 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.8 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.01 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $108B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...